Dear Fellow Scientists and Friends,
Vision Genomics, LLC, a company dedicated to drug discovery for aging and age-related diseases, in collaboration with InSilico Medicine, Inc. has recently published new research titled “Signaling pathway activation drift during aging: Hutchinson‐Gilford Progeria Syndrome fibroblasts are comparable to normal middle‐age and old‐age cells”. Please find attached a press article for immediate realease for this paper, published in the Journal ‘Aging’.
The research sheds light on the similarity between Hutchinson-Gliford Progeria Syndrome (HGPS or Progeria) and normal cellular aging and reveals common signaling pathway activation states in fibroblasts from HGPS patients and normal middle and old-aged individuals. The authors hope that the pathways exposed through this comparative study can be used as targets to develop drugs and drug combinations for HGPS as well as normal aging.
Please feel free to contact me at the address below for more information.
Best Regards,Riya R. Kanherkar Press Contact: Riya R. Kanherkar Vision Genomics, LLC(202) 910-8023 email@example.com